Patent · US Active

Methods for deriving dopaminergic neurons from pluripotent stem cells

US12104170B2 · kind B2 · utility

1Cited by
2References
37Claims
0Family size

Inventors

Key dates

Filing dateJun 28, 2021
Grant dateOct 1, 2024
Priority date
Expiry dateJun 28, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2506/45
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present application discloses a method of producing dopaminergic neurons from human stem cells by adding or increasing concentration of vitamin into neuro basal media at approximately Day 20+/−3 of a protocol for differentiating pluripotent stem cells into dopaminergic neurons.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.